After-Hours Movers 10/17: (MLNX) (GIVN) (NVAX) (KORS) Higher; (ALGN) (ALB) (AXP) Lower (more...)
Tweet
Share
E-mail
Get Alerts MLNX Hot Sheet
Join SI Premium – FREE
Mellanox Technologies, Ltd. (NASDAQ: MLNX) 26% LOWER; reported Q3 EPS of $1.37, $0.24 better than the analyst estimate of $1.13. Revenue for the quarter came in at $156.5 million versus the consensus estimate of $153.07 million. Mellanox sees Q4 revenues of $145-$150 million, versus the consensus of $157 million
Align Technology, Inc. (NASDAQ: ALGN) 16% LOWER; misses Q3 views, guides Q4 below the Street
ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) 13% LOWER; intends to offer shares of its common stock and warrants in an underwritten public offering
Gold Resource Corporation (AMEX: GORO) 13% LOWER; Updates on Q3 Production; Lowers FY12 Production Outlook
MannKind Corporation (Nasdaq: MNKD) 13% LOWER; intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.
Given Imaging (NASDAQ: GIVN) 12% HIGHER; is currently evaluating a range of strategic options, including preliminary non-binding indications of interest received from a number of parties relating to a possible merger or sale of the Company. The Company intends to continue to actively explore these and other alternatives, including a strategic alliance or additional acquisitions such as the recently announced acquisition of the assets of The Smart Pill Corporation.
CytRx Corporation (Nasdaq: CYTR) 10% LOWER; intends to commence a public offering of its common stock
Novavax (NASDAQ: NVAX) 7% HIGHER; Achieves Primary Objectives in A/H5N1 Phase 1
Albemarle Corp. (NYSE: ALB) 4% LOWER; reported Q3 EPS of $1.10, $0.02 better than the analyst estimate of $1.08. Revenue for the quarter came in at $662.1 million versus the consensus estimate of $670.18 million.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) 4% LOWER; commenced an offering to sell shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
Stryker Corp. (NYSE: SYK) 2% LOWER; reported Q3 EPS of $0.97, $0.01 worse than the analyst estimate of $0.98. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.07 billion. Stryker Corp. sees FY2012 EPS of $4.04-4.07, versus prior guidance of $4.25-4.40 and the consensus of $4.09.
Xilinx, Inc. (NASDAQ: XLNX) 1% LOWER; reported Q2 EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $543.9 million versus the consensus estimate of $547.74 million. Sees Q3 sales down 1% to down 5% sequentially.
American Express Co. (NYSE: AXP) 1% LOWER; reported Q3 EPS of $1.09, in-line with the analyst estimate of $1.09. Revenue for the quarter came in at $7.9 billion versus the consensus estimate of $7.93 billion.
Lam Research Corp (NASDAQ: LRCX) 1% HIGHER; reported Q1 EPS of $0.53, $0.12 better than the analyst estimate of $0.41. Revenue for the quarter came in at $906.9 million versus the consensus estimate of $903.68 million
Michael Kors Holdings Ltd. (NASDAQ: KORS) 1% HIGHER; new Buy rating
Align Technology, Inc. (NASDAQ: ALGN) 16% LOWER; misses Q3 views, guides Q4 below the Street
ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) 13% LOWER; intends to offer shares of its common stock and warrants in an underwritten public offering
Gold Resource Corporation (AMEX: GORO) 13% LOWER; Updates on Q3 Production; Lowers FY12 Production Outlook
MannKind Corporation (Nasdaq: MNKD) 13% LOWER; intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.
Given Imaging (NASDAQ: GIVN) 12% HIGHER; is currently evaluating a range of strategic options, including preliminary non-binding indications of interest received from a number of parties relating to a possible merger or sale of the Company. The Company intends to continue to actively explore these and other alternatives, including a strategic alliance or additional acquisitions such as the recently announced acquisition of the assets of The Smart Pill Corporation.
CytRx Corporation (Nasdaq: CYTR) 10% LOWER; intends to commence a public offering of its common stock
Novavax (NASDAQ: NVAX) 7% HIGHER; Achieves Primary Objectives in A/H5N1 Phase 1
Albemarle Corp. (NYSE: ALB) 4% LOWER; reported Q3 EPS of $1.10, $0.02 better than the analyst estimate of $1.08. Revenue for the quarter came in at $662.1 million versus the consensus estimate of $670.18 million.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) 4% LOWER; commenced an offering to sell shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
Stryker Corp. (NYSE: SYK) 2% LOWER; reported Q3 EPS of $0.97, $0.01 worse than the analyst estimate of $0.98. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.07 billion. Stryker Corp. sees FY2012 EPS of $4.04-4.07, versus prior guidance of $4.25-4.40 and the consensus of $4.09.
Xilinx, Inc. (NASDAQ: XLNX) 1% LOWER; reported Q2 EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $543.9 million versus the consensus estimate of $547.74 million. Sees Q3 sales down 1% to down 5% sequentially.
American Express Co. (NYSE: AXP) 1% LOWER; reported Q3 EPS of $1.09, in-line with the analyst estimate of $1.09. Revenue for the quarter came in at $7.9 billion versus the consensus estimate of $7.93 billion.
Lam Research Corp (NASDAQ: LRCX) 1% HIGHER; reported Q1 EPS of $0.53, $0.12 better than the analyst estimate of $0.41. Revenue for the quarter came in at $906.9 million versus the consensus estimate of $903.68 million
Michael Kors Holdings Ltd. (NASDAQ: KORS) 1% HIGHER; new Buy rating
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Investing.com’s stocks of the week
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours Movers, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
